Interview with Dr. Paolo Ascierto: Advances in Immunotherapy and Melanoma
b'Caris Precision Oncology Alliance\\u2122 Chairman, Dr. Chadi Nabhan, sits down with Dr. Paolo Ascierto, Director of the Unit of Melanoma and the Oncological Immunotherapy and Innovative Therapies Director at the National Tumor Institute \\u201cFondazione G. Pascale\\u201d, in Naples, Italy. As the founder of both the Melanoma Bridge Meeting\\xa0and the Immunotherapy Bridge Meeting, Dr. Ascierto shares outcomes from both meetings as well as insights into the latest treatments in both disease states.\\n\\nFor more information, please visit: www.CarisLifeSciences.com'